Molecular Profiling of Neuroendocrine Malignancies to Identify Prognostic and Therapeutic Markers: A Fox Chase Cancer Center Pilot Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.229
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Matthew Seiden Named President and CEO of Fox Chase Cancer Center

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2007English

Molecular Prognostic Markers in Pancreatic Cancer

Cancer Control
MedicineOncologyHematology
2000English

Novel Prognostic Molecular Markers in Lung Cancer (Review)

Oncology Letters
Cancer ResearchOncology
2020English

Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status

Current Colorectal Cancer Reports
HepatologyOncologyGastroenterology
2011English

The Next Thing in Prognostic Molecular Markers: microRNA Signatures of Cancer

Gut
Gastroenterology
2010English

Metabolomic Profiling to Identify Molecular Biomarkers of Cellular Response to Methotrexate in Vitro

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Insights Into Orphan Nuclear Receptors as Prognostic Markers and Novel Therapeutic Targets for Breast Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2015English

A Pilot Proteogenomic Study With Data Integration Identifies McT1 and GLUT1 as Prognostic Markers in Lung Adenocarcinoma

PLoS ONE
Multidisciplinary
2015English

Global Gene Expression Analysis to Identify Molecular Markers of Uterine Receptivity and Embryo Implantation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy